These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3606082)

  • 21. New Gene Responsible for Resistance of Clinical Corynebacteria to Macrolide, Lincosamide and Streptogramin B.
    Szemraj M; Kwaszewska A; Szewczyk EM
    Pol J Microbiol; 2018 Jun; 67(2):237-240. PubMed ID: 30015464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of new quinolones against clinical isolates of Corynebacterium species].
    Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
    Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between disk diffusion and agar dilution methods to determine in vitro susceptibility of Corynebacterium spp. clinical isolates and update of their susceptibility.
    Barberis CM; Sandoval E; Rodriguez CH; Ramírez MS; Famiglietti A; Almuzara M; Vay C
    J Glob Antimicrob Resist; 2018 Sep; 14():246-252. PubMed ID: 29782954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibilities and biotypes of Arcanobacterium haemolyticum blood isolates.
    Carlson P; Korpela J; Walder M; Nyman M
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):915-7. PubMed ID: 10691208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs.
    Prescott JF
    J Vet Pharmacol Ther; 1981 Mar; 4(1):27-31. PubMed ID: 7349320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents.
    Woolcock JB; Mutimer MD
    Antimicrob Agents Chemother; 1980 Dec; 18(6):976-7. PubMed ID: 7235683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of Corynebacterium group D2 from clinical specimens.
    Van Bosterhaut B; Claeys G; Gigi J; Wauters G
    Eur J Clin Microbiol; 1987 Aug; 6(4):418-9. PubMed ID: 3665897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases.
    Otsuka Y; Ohkusu K; Kawamura Y; Baba S; Ezaki T; Kimura S
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):109-14. PubMed ID: 16406181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium.
    Traub WH; Geipel U; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(4):230-7. PubMed ID: 9681199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Multidrug-Resistant Corynebacterium spp. Isolated from Blood Cultures of Hospitalized Patients in Japan.
    Qin L; Sakai Y; Bao R; Xie H; Masunaga K; Miura M; Hashimoto K; Tanamachi C; Hu B; Watanabe H
    Jpn J Infect Dis; 2017 Mar; 70(2):152-157. PubMed ID: 27357981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
    Bayston R
    Clin Infect Dis; 1995 Jul; 21(1):223. PubMed ID: 7578739
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicrobial susceptibilities of a Corynebacterium CDC group I1 strain isolated from a patient with endocarditis.
    Malanoski GJ; Parker R; Eliopoulos GM
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1329-31. PubMed ID: 1416833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Wound infections due to opportunistic corynebacterium species].
    Olender A; Łetowska I
    Med Dosw Mikrobiol; 2010; 62(2):135-40. PubMed ID: 20873486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocarditis due to Corynebacterium pseudodiphtheriticum: five case reports, review, and antibiotic susceptibilities of nine strains.
    Morris A; Guild I
    Rev Infect Dis; 1991; 13(5):887-92. PubMed ID: 1962103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug-Resistant, Opportunistic Pathogen.
    McMullen AR; Anderson N; Wallace MA; Shupe A; Burnham CA
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation, speciation, and antibiogram of clinically relevant non-diphtherial Corynebacteria (Diphtheroids).
    Reddy BS; Chaudhury A; Kalawat U; Jayaprada R; Reddy G; Ramana BV
    Indian J Med Microbiol; 2012; 30(1):52-7. PubMed ID: 22361761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urethritis due to Corynebacterium glucuronolyticum.
    Galan-Sanchez F; Aznar-Marin P; Marin-Casanova P; Garcia-Martos P; Rodriguez-Iglesias M
    J Infect Chemother; 2011 Oct; 17(5):720-1. PubMed ID: 21437677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
    Soriano F; Zapardiel J; Nieto E
    Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.
    Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a new selective medium for the isolation of Corynebacterium urealyticum.
    Zapardiel J; Nieto E; Soriano F
    J Med Microbiol; 1998 Jan; 47(1):79-83. PubMed ID: 9449953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.